Oral Prolonged Release Oxycodone Naloxone Combination Reduces Opioid-induced Constipation In Severe Chronic Pain Patients, With No Loss Of Analgesia

The addition of oral prolonged release (PR) naloxone, an opioid antagonist, to the opioid PR oxycodone significantly reduces opioid-induced constipation (OIC) in severe chronic pain patients without affecting analgesia, according to three new studies presented at this year's British Pain Society Annual Scientific Meeting in Liverpool.

Genome Study Casts New Light On The Origin Of Type 2 Diabetes

Type 2 Diabetes is a chronic disease with rising prevalence rates throughout the world. In Germany, about 8 million people are affected. These numbers could even be an underestimation as a relatively high number of undiagnosed diabetics remains. The newly-published meta analysis 1) on the genetics of type 2 diabetes casts new light on the origin of this disease.

Actemra Approved In Japan To Treat Patients With Rheumatoid Arthritis

Roche announced that their alliance partner company Chugai has received approval in Japan for the use of its innovative treatment, Actemra (tocilizumab), in patients suffering from rheumatoid arthritis (RA).

Aquilion ONE, World's First Dynamic Volume Computed Tomography Scanner With 320 Simultaneous Slices

Toshiba Medical Systems has introduced the Aquilion ONE CT scanner, a revolution in Computed Tomography (CT) technology that dramatically shortens the diagnosis of cardiac and stroke patients to a fraction of the usual time.

First Demonstration Of Human SRC Inhibition Achieved With Astrazeneca's Phase II Compound, AZD0530

AstraZeneca presented data at the American Association for Cancer Research (AACR) meeting about AZD0530, the first novel anti-cancer agent to demonstrate statistically significant inhibition of the Src pathway in human tumour tissue.1This is an important step because Src kinases are a family of molecules that play an important role in cancer growth and spread.

Half Of Europe's Workforce Remain Unprotected From Secondhand Smoke At Work

Less than a third of the European Union's Member States have introduced fully comprehensive smokefree legislation, three years after the world's first public health treaty on tobacco control - the World Health Organisation (WHO) Framework Convention on Tobacco Control (FCTC) - introduced the need for protecting employees from the dangerous effects of secondhand smoke.

New Type 2 Diabetes Drug, UK

A new drug to treat Type 2 diabetes has been launched in the UK. Vildagliptin, which comes in tablet form and is taken once or twice a day, is part of a class of drugs called DPP-4 (dipeptidyl peptidase-4) inhibitors.

Painless Hemorrhoid Treatment Featured In Leading Physicians' Magazine

The Ultroid Hemorrhoid Treatment, which provides an innovative and non-surgical approach to treating hemorrhoids, was recently featured in Physicians Office Resource. The trade magazine features products and editorials directly targeted to individuals in the medical profession.

New Data Show Treatment Of Multiple Sclerosis MS With AVONEX reg; interferon Beta-1a Enhances Quality Of Life

Results from a one-year prospective, observational study conducted to determine the impact of beginning treatment with AVONEX on MS patients' overall quality of life (QoL) were announced today. The data showed that patients receiving treatment with AVONEX experienced statistically significant improvements in QoL, as measured by the EuroQol questionnaire (EQ-5D), compared to baseline.

Medical And Healthcare Businesses Reacting Bullishly To The Credit Crunch, UK

Despite the pressures, medical and healthcare businesses appear to be reacting bullishly to the credit crunch according to a new study released today. When asked if they had to start their business again in today's economic climate, 78% of medical and healthcare businesses would do it all again tomorrow.